Inactive Instrument

Cerebain Biotech Corp.

Equities

CBBT

US15672M1062

Biotechnology & Medical Research

Cerebain Biotech Corp. Appoints Saini Chairman of its Scientific Advisory Board

June 18, 2013 at 01:39 am IST

Cerebain Biotech Corp. a subsidiary of Discount Dental Materials Inc. announced the appointment of Dr. Surinder Saini as Chairman of its Scientific Advisory Board. Dr. Surinder Saini is Board-certified Gastroenterologist practicing in Orange County, California since 1992.

Latest news about Cerebain Biotech Corp.

Diabetes Reversal Group, LLC announced that it has received funding from Cerebain Biotech Corp.	29/22/29	CI
Cerebain Biotech Corp. completed the acquisition of Assets of PKG, Inc.	20/21/20	CI
Cerebain Biotech Corp. entered into a Letter of Intent to acquire Assets of PKG, Inc.	25/20/25	CI
Cerebain Biotech Corp Announces Resignation of Wesley D. Tate as Chief Financial Officer, Chief Operating Officer and as Member of Its Board of Directors	24/19/24	CI
Cerebain Biotech Corp. Reports Earnings Results for the Third Quarter Ended March 31, 2019	20/19/20	CI
Cerebain Biotech Corp. announced that it expects to receive $0.11 million in funding from Auctus Fund Management, LLC	15/19/15	CI
Cerebain Biotech Corp. Reports Earnings Results for the Second Quarter Ended December 31, 2018	20/19/20	CI
Cerebain Biotech Corp. announced that it has received $0.05 million in funding from Jefferson Street Capital LLC	10/18/10	CI
Cerebain Is Considering Multiple Strategic Alternatives	04/18/04	CI
Cerebain Biotech Corp. Auditor Raises 'Going Concern' Doubt	26/18/26	CI
Cerebain Biotech Corp. Auditor Raises 'Going Concern' Doubt	15/17/15	CI
Cerebain Biotech Corp. announced that it has received $0.1 million in funding	24/17/24	CI
Cerebain Biotech Corp. announced that it expects to receive $0.1 million in funding	29/17/29	CI
Cerebain Biotech May Look At Strategic Alternatives	09/17/09	CI
Cerebain Biotech Corp. Auditor Raises 'Going Concern' Doubt	27/16/27	CI
Cerebain Biotech and Mossakowski Medical Research Centre Sign Memorandum of Understanding	23/16/23	CI
Cerebain Biotech Announces Business Relocation into the Heart of Orange County, California	04/16/04	CI
Cerebain Biotech Announces Plans to Seek FDA Approval	27/16/27	CI
Cerebain Biotech Names Azad L. Sheikh to Scientific Advisory Board	12/16/12	CI
Cerebain Biotech Corp. announced that it has received $0.3 million in funding from Geronimo Middle East and Africa	08/15/08	CI
Cerebain Biotech Appoints Mustafa Husain to Scientific Advisory Board	29/15/29	CI
Cerebain Biotech Corp. will Change its Ticker to CBBT from DDOO.D	18/14/18	CI
Discount Dental Materials Inc has Changed its Name to Cerebain Biotech Corp	20/14/20	CI
Cerebain Biotech Corp. has Changed its Ticker to CBBT from DDOO	19/14/19	CI
Discount Dental Materials, Inc. has Changed its Name to Cerebain Biotech Corp	19/14/19	CI

Chart Cerebain Biotech Corp.

Duration

Period

More charts

Company Profile

Cerebain Biotech Corp. is a biomedical company. The Company operates as a development-stage medical device company focused on the creation and clinical development of a minimally invasive implantable device. The Company, through its subsidiary, Cerebain Operating, Inc., is involved in the discovery of products for the treatment of Alzheimer's disease utilizing Omentum. The Omentum is a layer of tissue lying over internal organs (such as the intestines) and has the ability to generate biological agents that nourish nerves and help them grow. The Company is focused on inclusion of both a medical device solution, as well as a synthetic drug solution in its products. The Company is in the process of preparing for initial clinical trials.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+52.24%	5.57TCr
LONZA GROUP AG	+41.08%	3.99TCr
IQVIA HOLDINGS INC.	-5.93%	3.96TCr
CELLTRION, INC.	-5.56%	2.82TCr
ICON PUBLIC LIMITED COMPANY	+15.77%	2.63TCr
ALNYLAM PHARMACEUTICALS, INC.	-19.63%	1.89TCr
MEDPACE HOLDINGS, INC.	+31.33%	1.22TCr
UNITED THERAPEUTICS CORPORATION	+26.55%	1.21TCr
BIO-TECHNE CORPORATION	+1.37%	1.21TCr

Other Biotechnology & Medical Research